Share

Frequency-tuned electromagnetic field therapy improves post-stroke motor function: A pilot randomized controlled trial.

AI: Melanie Research RF Safe Research Library Jan 1, 2022 REASSURANCE MEDIUM

This pilot randomized, sham-controlled, double-blind trial evaluated extremely low frequency, low-intensity ENTF electromagnetic field therapy in subacute ischemic stroke patients with impaired upper extremity function. The per-protocol results reported greater improvements in motor function and disability outcomes in the active ENTF group compared with sham. No treatment-related adverse events were reported, and the authors call for larger multicenter confirmation.

Key points

  • The study used a randomized, sham-controlled, double-blind design in subacute ischemic stroke patients.
  • Exposure was extremely low frequency, low-intensity EMF stimulation (1–100 Hz, <1 G) delivered 40 minutes per session for 8 weeks.
  • Primary outcome was change in FMA-UE from baseline to 8 weeks, with additional upper extremity and global disability measures assessed.
  • Per-protocol results reported greater early improvement (week 4) in FMA-UE with ENTF versus sham.
  • Favorable week 8 differences were also reported for Action Research Arm Test (Pinch), Box and Blocks Test, and modified Rankin Scale.
  • No treatment-related adverse events were reported in the abstract.
  • The authors describe the findings as preliminary and recommend confirmation in larger multicenter studies.

Referenced studies & papers

Source: Open original

AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.